Oxigênio-ozônio em condições dermatológicas: evidências clínicas, mecanismos biológicos e limites terapêuticos
Revista ft · 31.10.2026 · 30 (163) · 01-20
DOI: 10.69849/6eb92b54 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 31.10.2026. Verfasst von Clauderci Dantas Barbosa und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Oxygen-ozone (O₂-O₃) therapy has been investigated as a complementary intervention in different dermatological conditions, particularly because of its potential antioxidant, immunomodulatory, antimicrobial, and tissue-repair effects. However, the consistency of the available evidence varies across different clinical indications.
Objective
To critically analyze the clinical evidence related to the use of O₂-O₃ in dermatological conditions, discussing its proposed biological mechanisms, therapeutic applications, safety profile, and limitations of the available literature.
Method
This is a critical theoretical review with an exploratory narrative approach, based on a literature search in PubMed/MEDLINE, including clinical studies, randomized trials, systematic reviews, and meta-analyses relevant to the dermatological applications of O₂-O₃.
Results
The most consistent evidence is concentrated on chronic wounds, particularly diabetic foot ulcers, and on some dermatoses, with findings related to wound healing, reduction in lesion area, and clinical or mycological response. For atopic dermatitis, the findings suggest potential clinical benefits related to modulation of the skin microbiota, whereas for acne, psoriasis, and cutaneous bacterial infections, the evidence remains limited or predominantly preliminary. The heterogeneity of concentrations, formulations, routes of administration, and treatment duration makes it difficult to establish standardized protocols.
Conclusion
O₂-O₃ has potential as a complementary intervention in specific dermatological conditions; however, its clinical application should consider the strength of evidence for each indication, patient safety, and the need to use it only as an adjunct to established therapies. More robust clinical trials and standardized protocols are still needed.
Zitieren
APA
Barbosa, C. D., & Filho, E. M. A. A. (2026). Oxigênio-ozônio em condições dermatológicas: evidências clínicas, mecanismos biológicos e limites terapêuticos. Revista ft, 30(163), 01-20. https://doi.org/10.69849/6eb92b54
Vancouver
Barbosa CD, Filho EMAA. Oxigênio-ozônio em condições dermatológicas: evidências clínicas, mecanismos biológicos e limites terapêuticos. Revista ft. 2026;30(163):01-20. doi:10.69849/6eb92b54
BibTeX
@article{Barbosa2026,
author = {Barbosa, Clauderci Dantas and Filho, Eder Magnus Almeida Alves},
title = {Oxigênio-ozônio em condições dermatológicas: evidências clínicas, mecanismos biológicos e limites terapêuticos},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {163},
pages = {01--20},
doi = {10.69849/6eb92b54}
}
EUVIMED